Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of KRAS Variant Subtypes With Survival and Recurrence in Patients With Surgically Treated Intrahepatic Cholangiocarcinoma.

JAMA surgery - 1 Jan 2022

Zhou Shao-Lai, Xin Hao-Yang, Sun Rong-Qi, Zhou Zheng-Jun, Hu Zhi-Qiang, Luo Chu-Bin, Wang Peng-Cheng, Li Jia, Fan Jia, Zhou Jian

Abstract excerpt

Importance: KRAS variants are associated with tumor progression; however, the prevalence of KRAS variant subtypes and their association with survival and recurrence in patients with intrahepatic cholangiocarcinoma (ICC) after curative resection are largely unknown. Objective: To explore the prognostic association of KRAS variant subtypes with survival and recurrence in patients with ICC. Design, Setting, and...

Topics

Join the communities discussing this publication.

Bile Duct Neoplasms
Biomarkers, Tumor
Cholangiocarcinoma
Hepatectomy
Neoplasm Recurrence, Local

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Proto-Oncogene Proteins p21(ras)

Source

Open in PubMed Open full text

Identifiers

PMID: 34730772
DOI: 10.1001/jamasurg.2021.5679
PMCID: PMC8567187

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of KRAS Variant Subtypes With Survival and Recurrence in Patients With Surgically Treated Intrahepatic Cholangiocarcinoma.PMID 34730772Read ↗

KRAS Variants Are Associated With Survival Outcomes and Genomic Alterations in Biliary Tract Cancers.Semantic proximity Read ↗

KRAS Allelic Variants in Biliary Tract Cancers.Semantic proximity Read ↗

Impact of genetic alterations on long-term outcomes in resectable intrahepatic cholangiocarcinoma: meta-analysis.Semantic proximity Read ↗

Genetic alterations of <i>KRAS</i> and <i>TP53</i> in intrahepatic cholangiocarcinoma associated with poor prognosisSemantic proximity Read ↗

Patient Outcomes in Resected Combined Hepatocellular Cholangiocarcinoma (cHCC-ICC) and Intrahepatic Cholangiocarcinoma: A Single Center StudySemantic proximity Read ↗

Molecular Profile of Intrahepatic CholangiocarcinomaSemantic proximity Read ↗

Mutational landscape of intrahepatic cholangiocarcinoma.Semantic proximity Read ↗

The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome.Semantic proximity Read ↗

Comprehensive Analysis of Genomic Mutation Signature and Tumor Mutation Burden for Prognosis of Intrahepatic CholangiocarcinomaSemantic proximity Read ↗

TP53 /KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic CholangiocarcinomaSemantic proximity Read ↗

Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.Semantic proximity Read ↗

Intrahepatic cholangiocarcinoma: current management and emerging therapies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.